Mesothelioma Misdiagnosis: 22.6% Missed
Up to a quarter of mesothelioma cases are first misdiagnosed. Learn the conditions it's confused with and why a second opinion matters.
The Misdiagnosis Problem
Mesothelioma is missed often enough that even mortality data underestimates it: roughly 22.6% of cases go unascertained on death certificates. That undercount, together with the disease’s rarity, its similarity to other conditions, and diagnostic limitations, is why a wrong or delayed diagnosis is a real risk during a patient’s care.
Getting the correct diagnosis matters because it determines which treatments are appropriate, whether you’re eligible for surgery, your overall prognosis, and access to clinical trials.
Common Misdiagnoses
When initial biopsies fail to detect mesothelioma, patients are typically diagnosed with:
| Misdiagnosis | Frequency |
|---|---|
| Chronic pleuritis | 71% of false-negatives |
| Atypical mesothelial hyperplasia | 28.5% of false-negatives |
| Reactive mesothelial proliferation | Small percentage |
| Lung cancer | Common initial suspicion |
| Pneumonia | Based on symptoms |
| COPD | Based on symptoms |
These conditions share histopathological features with mesothelioma, making differentiation difficult without expert pathological review.
Diagnostic Accuracy by Method
Pleural Cytology (Fluid Analysis)
- Diagnostic in only 32% of patients with suspected mesothelioma
- Often the first test performed
- Low sensitivity means tissue biopsy is usually needed
Video-Assisted Thoracic Surgery (VATS) Biopsy
At high-volume specialized centers:
- False-negative rate: Only 2%
- Sensitivity: 93%
- Specificity: 100%
However, in the broader literature:
- False-negative rates range from 5% to 25%
- Accuracy depends heavily on institutional experience
Why the Variation?
Diagnostic accuracy depends on:
- Pathologist experience with mesothelioma
- Tissue sample quality and quantity
- Immunohistochemistry panels used
- Institutional volume of mesothelioma cases
Time to Correct Diagnosis
When patients receive a false-negative initial biopsy:
- Median time to correct diagnosis: 160 days (over 5 months)
- This delay can affect treatment options
- Stage may progress during this period
Why Mesothelioma Is Hard to Diagnose
The Rarity Problem
Mesothelioma is rare. Only about 3,000 new cases are diagnosed per year in the US. Many physicians never see a case in their careers, and pathologists outside mesothelioma centers may lack experience identifying the tumor.
Overlapping Symptoms
Mesothelioma symptoms mimic common conditions:
- Shortness of breath → COPD, pneumonia, heart failure
- Chest pain → cardiac issues, musculoskeletal
- Pleural effusion → many possible causes
- Fatigue → countless conditions
How the Tissue Misleads Pathologists
Under the microscope:
- Mesothelioma cells can look like other cancers
- Reactive mesothelial cells can mimic cancer
- Adenocarcinoma and mesothelioma can appear similar
- Specialized staining is required for accurate diagnosis
Getting an Accurate Diagnosis
1. Disclose Asbestos Exposure History
Tell every healthcare provider about:
- Occupational exposure (jobs, dates, locations)
- Secondary exposure (family member’s work)
- Environmental exposure (home renovations, locations)
This information changes how physicians evaluate your symptoms.
2. Request Tissue Biopsy
If pleural fluid analysis is inconclusive:
- Ask about VATS biopsy
- Tissue provides more diagnostic information than fluid
- Multiple samples improve accuracy
3. Get a Second Opinion
For any cancer diagnosis, but especially rare cancers:
- Seek review at a mesothelioma specialty center
- Have pathology slides reviewed by expert pathologists
- Consider NCI-designated cancer centers
If clinical suspicion remains high despite negative biopsy, pursue iterative biopsies. Repeat biopsy may be warranted. Discuss with your physician. A 160-day delay to correct diagnosis can significantly impact treatment options.
Specialized Pathology Review
Expert mesothelioma pathologists use:
Immunohistochemistry Panel
| Marker | Mesothelioma | Adenocarcinoma |
|---|---|---|
| Calretinin | Positive | Negative |
| WT-1 | Positive | Negative |
| D2-40 | Positive | Negative |
| CK5/6 | Positive | Negative |
| CEA | Negative | Positive |
| TTF-1 | Negative | Positive |
Using multiple markers improves diagnostic accuracy.
BAP1 Testing
- Loss of BAP1 expression strongly suggests mesothelioma
- Helps distinguish from reactive mesothelial cells
- Can identify hereditary predisposition
Racial and Ethnic Disparities
Research shows diagnostic timing varies by demographics:
- Black and Asian/Pacific patients tend to receive diagnoses later than white patients
- Likely reflects healthcare access disparities
- Earlier diagnosis correlates with better outcomes
When to Suspect Misdiagnosis
Question your diagnosis if:
- You have documented asbestos exposure but were diagnosed with something else
- Treatment for the diagnosed condition isn’t working
- Symptoms are progressing despite treatment
- Initial testing was limited (cytology only, no tissue biopsy)
- Diagnosis was made at a non-specialty center
Finding Expert Review
Several places offer expert second opinions. NCI-designated cancer centers maintain pathology departments with mesothelioma expertise. Mesothelioma specialty centers such as Memorial Sloan Kettering, MD Anderson, Dana-Farber, Mount Sinai, and the University of Pennsylvania Abramson Cancer Center see enough cases to recognize subtle variants. Academic medical centers often have mesothelioma expertise, and the treating oncologist can arrange pathology review directly.
The Cost of Delayed Diagnosis
A 5-month delay in diagnosis has real consequences. The cancer can progress to a higher stage. Surgical options like pleurectomy/decortication or cytoreductive surgery with HIPEC may no longer be feasible. Earlier treatment generally produces better outcomes, and months lost to a wrong diagnosis are months not spent on effective therapy.
References
Journal of Clinical Medicine. (2025). The Accuracy of Video-Assisted Thoracic Surgery Pleural Biopsy in Patients with Suspected Diffuse Pleural Mesothelioma: A Real-Life Study.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12787047/
The Open Epidemiology Journal. (2011). Monte Carlo Analysis of Impact of Underascertainment of Mesothelioma Cases on Underestimation of Risk.
https://benthamopen.com/ABSTRACT/TOEPIJ-4-45
Reader Q&A
Frequently Asked Questions
Was tissue biopsy performed, or only fluid analysis?
Pleural fluid analysis alone is diagnostic in only 32% of cases. Tissue biopsy (ideally VATS biopsy) provides much better accuracy. If only fluid was analyzed and results were inconclusive, request tissue biopsy.
What immunohistochemistry markers were tested?
Multiple markers should be tested: calretinin, WT-1, D2-40, CK5/6 (positive in mesothelioma) and CEA, TTF-1 (negative in mesothelioma). Using multiple markers improves diagnostic accuracy.
Has a pathologist with mesothelioma experience reviewed my case?
Mesothelioma is rare. Many pathologists have limited experience with it. Expert review at a specialty center can catch errors. High-volume centers have only 2% false-negative rates vs 5-25% elsewhere.
Should I seek a second opinion at a specialty center?
Yes, especially if you have documented asbestos exposure, initial testing was limited, diagnosis was made at a non-specialty center, or you’re uncertain about the diagnosis.
Is mesothelioma often misdiagnosed?
Mesothelioma is frequently reported as misdiagnosed, largely because it is rare and its early symptoms resemble far more common illnesses like bronchitis, pneumonia, COPD, and even flu or heart disease. Several sources estimate that around 14% to nearly 25% of mesothelioma cases in the United States are initially misdiagnosed, and a separate epidemiology study found that about 22.6% of cases go unascertained on death certificates, which means even mortality data undercounts the disease. People with mesothelioma are sometimes first told they have lung cancer or other gastrointestinal or gynecologic cancers, since imaging and even biopsy findings can look similar. Research in pathology journals describes individual cases where mesothelioma was mistaken for lung adenocarcinoma until more advanced testing, such as specialized immunohistochemical markers, clarified the diagnosis. Legal and medical centers note that this pattern of misdiagnosis can delay appropriate treatment and may worsen outcomes, which is why misdiagnosis is a prominent topic in both clinical literature and asbestos-related litigation handled by trial lawyers and attorneys.
What's worse, lung cancer or mesothelioma?
Evidence from cancer registries and advocacy groups shows that mesothelioma is generally rarer but often more aggressive than lung cancer, with a consistently poorer long‑term outlook. Multiple sources report 5‑year survival for people with mesothelioma in the range of about 10–15%, compared with roughly 18–33% for many forms of lung cancer, depending on type and stage. Some reports note that early-stage non‑small cell lung cancer can reach 5‑year survival near 60–67%, while early-stage mesothelioma lags behind at around 18–23%. Both cancers can severely affect quality of life, but lung cancer outcomes tend to be more variable, while mesothelioma is more strongly tied to asbestos exposure and often diagnosed later. Trial lawyers and advocacy groups frequently highlight this survival gap when discussing asbestos cases and compensation trends.
What are the signs that mesothelioma is getting worse?
As mesothelioma advances, people with the disease often experience worsening shortness of breath, even at rest, increased chest or abdominal pain, and difficulty eating or drinking, leading to rapid weight loss. Other signs include excessive daytime sleeping, confusion, reduced mobility requiring assistance, and persistent fatigue or coughing. Comorbidities like COPD or fluid buildup (pleural effusion or ascites) can accelerate these symptoms by further impairing lung function. Evidence from clinical descriptions shows these changes typically occur in later stages, shifting focus to comfort care.
Where does mesothelioma cancer usually start?
Mesothelioma most commonly starts in the pleura, the thin membrane lining the lungs, accounting for the majority of cases. The cancer can also develop in the peritoneum, the lining of the abdominal cavity, or more rarely in the pericardium (heart lining) or tunica vaginalis testis. Asbestos fibers that are inhaled travel to the ends of small air passages and reach the pleura, where they can cause inflammation, scarring, and DNA damage that leads to uncontrolled cell growth. If asbestos fibers are swallowed, they can reach the abdominal lining and contribute to peritoneal mesothelioma.